News

Latest News

14th April 2010 Richmond Pharmacology’s Volunteer Database Exceeds 100,000 Volunteer Registration Records Richmond Pharmacology registered its 100,000th volunteer on Tuesday the 16th of February 2010, – making our Volunteer Database the UK’s single largest database for clinical trial participation. VORSPRUNG RPL recently completed the recruitment for a POC/PD trial requiring 70 patients suffering from Relapsing Remitting Multiple Sclerosis; this was done in just 6 months, which to our knowledge is the fastest ever recruitment project in this patient population. This has allowed the sponsor significantly faster decision making. RPL also recently completed the recruitment for Europe’s first paediatric clinical trial in healthy adolescent girls. Recruitment commenced within days from Ethics Committee approval and was completed in less than two weeks. RPL is currently conducting a large scale dose escalation study requiring the inclusion of 72 Japanese for a specialist anesthetic study where each participant is to be anesthetized. Our unique capability to recruit large panels of first generation Japanese male and female volunteers has made us the leading provider of these studies in Europe. DURCH From the inception of the company, the recruitment process was given an equal footing within the company through the installation of a dedicated professional recruitment team, which has been the largest and most effective of any early phase CRO in the UK along with a strong branded marketing presence within the general population. This has enabled RPL to recruit a multitude of volunteer panels including special panels such as young healthy, elderly healthy, Japanese and patients from primary and secondary care quickly and efficiently. Multiple feedback loops within our custom built database system has always allowed us to steer towards meeting out recruitment targets in time even when timelines are moved at short notice; capabilities for which RPL is well recognized within the industry in addition to our renowned First Time in Human and TQT/cardiac safety capabilities. INNOVATION Staying ahead of the competition is essential to our continuing success as a contract research organisation. This combined with a proprietary volunteer database in excess of 100,000 strong, means that we can guarantee the delivery of a variety of healthy volunteer and patient panels on time and within budget. Book your site visit today; You can be confident that Richmond Pharmacology will always rise to the challenge!

1st March 2010 Richmond Pharmacology (RPL) will be attending this month’s 22nd Annual DIA EuroMeeting, taking place 8-10 March 2010 in Monaco. The DIA Annual EuroMeeting features more than 110 hot-topic sessions across 13 themes and attracts more than 3,000 professionals from the biopharmaceutical industry, contract service organisations, regulatory agencies, health ministries and academia, as well as patients and students worldwide. Themes are based on an integrated multidisciplinary approach that will generate interest from as many disciplines as possible. This year’s themes include: Innovation Staying in Business: How to Make Sure You Comply with All Rules and Regulations Paediatric Medicines on Their Way to Patients Decision Making: The Key to Efficient and Effective Drug Development, approval, and access Paving the Way for Advanced Therapies: Fostering New Generations of Biotechnology-Derived Medicines Challenges for Switching from Prescription to Non-Prescription Status through the Centralised Procedure Personalised Medicines: What Is It, Where Do We Stand, and Where Are We Going? Taking the European Regulatory Infrastructure Forward Risk Management The Informed Patient eHealth Pharmaceutical Sciences in 2020 Handling Clinical Trials, eSubmissions and Quality Requests Click here to download advanced programme. RPL will be exhibiting at this year’s DIA EuroMeeting to inform key decision makers in the industry of our expertise and experience in the field of Early Phase Research. The EuroMeeting is a key event in the calendar and this forum provides an ideal opportunity to meet with existing clients, network and connect with new prospective sponsors. Planning to attend? We look forward to seeing you in Monaco next month!